{"ok":true,"trend":{"id":830341,"platform":"news","region":"global","key":"prime medicine (nasdaq:prme) cut to \"sell\" at wall street zen","title":"Prime Medicine (NASDAQ:PRME) Cut to \"Sell\" at Wall Street Zen","url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOUnkxaWdQdmk3ZmM1ODJqYU50MWJqNG5ha3h1QXNwb1lTUkhYcWFzaFNIVEFSWUYwSzlCTjF4SHdGbkdtVUtCWDI5cEtPTlQxMzZadF94SFZtZVN3Q3huNzhabEtaMENUdy1MNm81OTVfY200UnVZY25qdXVQTjQ2MjAydnNzX3AxWHhmN0RWeUxJclMtVzd3c08zUFpTSTAwSVhBTTJucEotdi11NEI4aTRuM183d1hhdGkw?oc=5","first_seen":"2026-10-03T07:01:36.453680Z","last_seen":"2026-10-03T11:08:59.736803Z","last_rank":36,"peak_rank":33,"last_volume":null,"peak_volume":0,"seen_count":3,"score":0.6609375,"category_hint":"medicine","section":"health","category":"medicine","summary":"Prime Medicine, the NASDAQ-listed gene editing company, was downgraded to a \"Sell\" rating by research firm Wall Street Zen. The move affects how investors view the stock, which trades under the ticker PRME. No further details on the rationale for the downgrade were provided in initial coverage.","why":"Investors are reacting to a fresh analyst downgrade of a biotech stock","tone":"neutral","entities":["Prime Medicine","Wall Street Zen","NASDAQ"],"summarized_at":"2026-10-03T07:02:03.431335Z","meta":{"via":"scan","lang":"en","term":"medicine","source":"marketbeat.com","published":"Sat, 03 Oct 2026 05:51:07 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"Prime Medicine Downgraded to Sell by Wall Street Zen","section_name":"Health","category_name":"Medicine","timeline":[{"captured_at":"2026-10-03T07:01:36.453680Z","rank":36,"volume":null},{"captured_at":"2026-10-03T08:23:30.285537Z","rank":33,"volume":null},{"captured_at":"2026-10-03T11:08:59.736803Z","rank":36,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOUnkxaWdQdmk3ZmM1ODJqYU50MWJqNG5ha3h1QXNwb1lTUkhYcWFzaFNIVEFSWUYwSzlCTjF4SHdGbkdtVUtCWDI5cEtPTlQxMzZadF94SFZtZVN3Q3huNzhabEtaMENUdy1MNm81OTVfY200UnVZY25qdXVQTjQ2MjAydnNzX3AxWHhmN0RWeUxJclMtVzd3c08zUFpTSTAwSVhBTTJucEotdi11NEI4aTRuM183d1hhdGkw?oc=5","author":"MarketBeat","title":"Prime Medicine (NASDAQ:PRME) Cut to \"Sell\" at Wall Street Zen","snippet":null,"posted_at":"2026-10-03T05:51:07Z","likes":null}],"elsewhere":[],"window":"7d"}}